Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov​.

Ebola virus disease (EVD) news, resources and funding for global health researchers

Ebola hemorrhagic fever is an acute viral disease that often leads to severe illness and death in humans and other primates. The infection typically affects multiple organs in the body and is often accompanied by hemorrhage. Once the virus has been transmitted from an animal host to a human, it can then spread through person-to-person contact.

Scientists employed and funded by NIH's National Institute of Allergy and Infectious Diseases (NIAID) have been working for decades to develop tests to diagnose Ebola virus early, therapies to treat illness caused by the virus, and vaccines to prevent infection. Because of the past outbreaks in West Africa, NIAID's Vaccine Research Center is supporting the development and testing of investigational vaccines. NIAID is also researching the long-term health effects of Ebola on survivors.

Fogarty is supporting grants to plan research training and capacity building programs focused on emerging viral epidemics in collaboration with institutions in Guinea, Liberia and Sierra Leone.

Related News and Information

• Dr. Christian Happi talks infectious disease in Africa
  Global Health Matters, November/December 2024
• Reflecting on a Historic Ebola Response
  CDC Global Health Center news, July 22, 2024
• Use of Ebola Vaccines — Worldwide, 2021–2023
  Morbidity and Mortality Weekly Report (MMWR), April 25, 2024
• Geographic Disparities in Domestic Pig Population Exposure to Ebola Viruses, Guinea, 2017–2019
  Emerging Infectious Diseases, April 2024
• Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions
  Emerging Infectious Diseases, April 2024
• Experimental Ebola Vaccines Found Safe and Capable of Producing Immune Responses in Healthy Adults
  NIAID news, April 3, 2024
• Experimental NIH Sudan virus vaccine protects macaques
  NIH/NIAID news, February 3, 2023
  

Focus: Fogarty’s response to Ebola: Where are we now?

Global Health Matters, July / August 2022

• Building a bench of researchers in post-Ebola Liberia
  
• South-South partnership bolsters the fight against viral disease in West Africa
  
• Developing a new generation of researchers in Sierra Leone
• Opinion: Fogarty’s continuing support of Ebola research is a point of pride

Related Video

Ebola in Zaire, 1976: The Past as Prologue: As part of the CDC lecture series, "The Past as Prologue," Fogarty senior scientist emeritus Dr. Joel Breman discussed his work in Zaire in 1976. September 5, 2019

NIH News and Resources

• About Ebola from NIAID
• About Ebola from NIH's MedlinePlus
  

Other US Government Resources

• U.S. Centers for Disease Control and Prevention (CDC) Ebola resources:
• CDC on Ebola (Ebola Virus Disease)
• CDC information for healthcare workers
• CDC Global Health Security Agenda
  
• United States Agency for International Development (USAID):
• USAID Ebola news and resources
  

Other Online Resources

• Ebola Resource Centre
  The Lancet
• Ebola toolbox
  from MEDBOX, the Aid Library, administered by the Medical Mission Institute, the Association for Overseas Medical Services, a non-profit advisory organization for international health, based in Würzburg, Germany
  
• Ebola in Context - Understanding Transmission, Response and Control
  Free online course from London School of Hygiene and Tropical Medicine

Updated August 15, 2025